Travere Therapeutics, Inc. Quarterly Common Stock, Shares, Issued from Q4 2011 to Q2 2024

Taxonomy & unit
us-gaap: shares
Description
Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.
Summary
Travere Therapeutics, Inc. quarterly Common Stock, Shares, Issued history and growth rate from Q4 2011 to Q2 2024.
  • Travere Therapeutics, Inc. Common Stock, Shares, Issued for the quarter ending June 30, 2024 was 76.5M shares, a 1.98% increase year-over-year.
Common Stock, Shares, Issued, Quarterly (shares)
Common Stock, Shares, Issued, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 76.5M +1.48M +1.98% Jun 30, 2024 10-Q 2024-08-01
Q1 2024 76.1M +1.52M +2.04% Mar 31, 2024 10-Q 2024-05-06
Q4 2023 75.4M +11.1M +17.2% Dec 31, 2023 10-Q 2024-08-01
Q3 2023 75.1M +11M +17.1% Sep 30, 2023 10-Q 2023-11-07
Q2 2023 75M +11.1M +17.4% Jun 30, 2023 10-Q 2023-08-03
Q1 2023 74.6M +11.1M +17.4% Mar 31, 2023 10-Q 2023-05-04
Q4 2022 64.3M +1.8M +2.88% Dec 31, 2022 10-K 2024-02-20
Q3 2022 64.2M +3.13M +5.13% Sep 30, 2022 10-Q 2022-10-27
Q2 2022 63.8M +3.13M +5.15% Jun 30, 2022 10-Q 2022-08-04
Q1 2022 63.5M +3.07M +5.09% Mar 31, 2022 10-Q 2022-05-05
Q4 2021 62.5M +10.2M +19.6% Dec 31, 2021 10-K 2023-02-23
Q3 2021 61M +10M +19.6% Sep 30, 2021 10-Q 2021-10-29
Q2 2021 60.7M +9.81M +19.3% Jun 30, 2021 10-Q 2021-07-29
Q1 2021 60.4M +17.3M +40% Mar 31, 2021 10-Q 2021-05-06
Q4 2020 52.2M +9.16M +21.3% Dec 31, 2020 10-K 2022-02-24
Q3 2020 51M +8.06M +18.8% Sep 30, 2020 10-Q 2020-11-05
Q2 2020 50.9M +8M +18.7% Jun 30, 2020 10-Q 2020-07-31
Q1 2020 43.2M +1.72M +4.14% Mar 31, 2020 10-Q 2020-05-11
Q4 2019 43.1M +1.7M +4.11% Dec 31, 2019 10-K 2021-03-01
Q3 2019 43M +1.79M +4.35% Sep 30, 2019 10-Q 2019-10-30
Q2 2019 42.9M +2.53M +6.26% Jun 30, 2019 10-Q 2019-08-06
Q1 2019 41.4M +1.56M +3.92% Mar 31, 2019 10-Q 2019-05-07
Q4 2018 41.4M +2.02M +5.12% Dec 31, 2018 10-K 2020-02-24
Q3 2018 41.2M +1.89M +4.8% Sep 30, 2018 10-Q 2018-11-01
Q2 2018 40.4M +2.08M +5.43% Jun 30, 2018 10-Q 2018-08-03
Q1 2018 39.9M +1.71M +4.49% Mar 31, 2018 10-Q/A 2018-07-06
Q4 2017 39.4M +1.47M +3.87% Dec 31, 2017 10-K 2019-02-26
Q3 2017 39.3M +1.58M +4.18% Sep 30, 2017 10-Q 2017-11-07
Q2 2017 38.3M +1.57M +4.26% Jun 30, 2017 10-Q 2017-08-09
Q1 2017 38.2M +1.57M +4.29% Mar 31, 2017 10-Q 2017-05-05
Q4 2016 37.9M +1.44M +3.95% Dec 31, 2016 10-K/A 2018-07-06
Q3 2016 37.7M +1.7M +4.71% Sep 30, 2016 10-Q 2016-11-04
Q2 2016 36.7M +1.65M +4.71% Jun 30, 2016 10-Q 2016-08-05
Q1 2016 36.6M +1.75M +5.01% Mar 31, 2016 10-Q 2016-05-05
Q4 2015 36.5M +10M +38% Dec 31, 2015 10-K 2017-03-01
Q3 2015 36M +9.31M +34.9% Sep 30, 2015 10-Q 2015-11-06
Q2 2015 35.1M +8.39M +31.5% Jun 30, 2015 10-Q 2015-08-10
Q1 2015 34.8M +10M +40.5% Mar 31, 2015 10-Q 2015-05-11
Q4 2014 26.4M +7.88M +42.5% Dec 31, 2014 10-K 2016-02-26
Q3 2014 26.7M +8.32M +45.3% Sep 30, 2014 10-Q 2014-11-13
Q2 2014 26.7M +14.4M +117% Jun 30, 2014 10-Q 2014-08-14
Q1 2014 24.8M +12.6M +103% Mar 31, 2014 10-Q 2014-05-15
Q4 2013 18.5M +9.59M +107% Dec 31, 2013 10-K/A 2015-07-09
Q3 2013 18.4M Sep 30, 2013 10-Q/A 2015-07-09
Q2 2013 12.3M Jun 30, 2013 10-Q 2013-09-16
Q1 2013 12.2M +12.1M +11326% Mar 31, 2013 10-Q/A 2013-09-16
Q4 2012 8.95M +4.91M +121% Dec 31, 2012 10-K/A 2015-07-09
Q1 2012 107K Feb 29, 2012 10-Q 2013-03-06
Q4 2011 4.04M Dec 31, 2011 10-K/A 2013-09-16
* An asterisk sign (*) next to the value indicates that the value is likely invalid.